full text:
Company is Shipping FLUARIX(R) and FLULAVAL(TM) to U.S. Customers for 2007- 2008 Season
GlaxoSmithKline (NYSE:GSK) today announced that it is supplying the U.S. market with a combined total of 30-35 million doses of the seasonal influenza virus vaccines Fluarix(R) (Influenza Virus Vaccine) and FluLaval(TM) (Influenza Virus Vaccine) - up from approximately 25 million doses in the 2006-2007 flu season. Supplies of the two vaccines are now shipping to U.S. customers for the 2007- 2008 influenza season.
"Providing an ample and steadily growing supply of flu vaccine has been a priority for GlaxoSmithKline since entering the U.S. market in 2004," said David Pernock, Senior Vice President, GlaxoSmithKline. "Over the years, GSK has significantly increased its influenza vaccine manufacturing capacity, and we have taken steps to improve the way this product is distributed to those who need it."
For more information: http://www.gsk.com/

Share this content via:HTML: for your myspace, blog, or web site

' />
BB: for your bulletin boards or forums
URL: for your Email, IM, or link to this page